Company / Operating Cash Flow per Share
LivaNova Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$4.68
FY2025
5-year range
-$1.87 / $4.68
FY2021-FY2025
Trend
+37.9%
vs FY2024
Sector context
#57 of 161
Health Care
What the data says
At $4.68, LivaNova's operating cash flow per share ranks #57 of 161 in the Health Care sector. Operating Cash Flow per Share has increased for 4 consecutive years, from $-1.87 in FY2021 to $4.68 in FY2025.
Based on SEC 10-K filings.
4.68 in FY2025.
Improved from $1.40 to $4.68 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#57 of 161 in Health CareTop 35% of 161This company $4.68 Sector average $6.64
▼
-29.5% below sector average
Key checks
Key Insights
- LivaNova's operating cash flow per share has grown for 4 consecutive years.
- In FY2025, operating cash flow per share increased 37.9% year-over-year.
- Ranks #57 out of 161 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.68 | +37.9% |
| FY2024 | $3.39 | +142.7% |
| FY2023 | $1.40 | +193.8% |
| FY2022 | -$1.49 | +20.4% |
| FY2021 | -$1.87 | -14.3% |
| FY2020 | -$1.64 | +13.3% |
| FY2019 | -$1.89 | -175.8% |
| FY2018 | $2.50 | +131106.7% |
| FY2017 | $0.00 | -99.9% |
| FY2016 | $3.47 | +1322.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026